GETTING MY LDN-27219 PHARMACOLOGICAL PROPERTIES TO WORK

Just one specifically fascinating compound is LDN-27219. While most tTG inhibitors are meant to bind to your protein crosslinking active site, LDN-27219 in its place binds for the nucleotide binding pocket of the enzyme though it's in its closed-condition conformation, and stabilizes that conformation to stop crosslinking activity.seventy eight Sch